{'text': 'Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study', 'publisher': {'href': 'https://www.nature.com', 'title': 'Nature.com'}, 'created_at': 'Tue, 06 Oct 2015 07:00:00 GMT', 'description': 'Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study  Nature.com', 'url': 'https://news.google.com/rss/articles/CBMiVEFVX3lxTE44QVdVcVQ2Q1Bqb2hhaS1MSjdlTWw1TkFCbG1EU2N5YVcwYWZidTRMMjdqMnhndTVRcjBvT0NUMGRJOWx4ekhqZk5sTDZKcklUWXdFOQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Icometrix Collaborates with Novartis on MSmetrix Software...', 'publisher': {'href': 'https://multiplesclerosisnewstoday.com', 'title': 'Multiple Sclerosis News Today'}, 'created_at': 'Tue, 06 Oct 2015 07:00:00 GMT', 'description': 'Icometrix Collaborates with Novartis on MSmetrix Software...  Multiple Sclerosis News Today', 'url': 'https://news.google.com/rss/articles/CBMi-AFBVV95cUxPUi1QNzZ4QVVKS0NfSzQxS2JGWDAwdkd4OWYwMFI1Tl9KaFdjaVdxV3F5NTE5VXp5cGEzbm1UcWRDWklFSzZBWThHcjlkOVpUUU1KM1h0ekV0OHpWeFdHaEg5c21IYXFVRXgzaW4xU05naVl4UmF3eERienV4TnBBR21xcldSUmszRmlzYlFEb2NkRVN6UkhET1RqaTB4b1Bsa2tWZWJrbEVqR20tY2huMEtXb01QRXJ0MjJ5NHNNVVYxWGhGcDFQbkl3R2gwZGZ1ckRNOUx6RE9JX3VQZ2FJb0FlOC1KNTZKYkZPNjNNaGxPS1UyRVRvcA?oc=5&hl=en-US&gl=US&ceid=US:en'}
